Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9915051 | Molecular and Cellular Endocrinology | 2005 | 8 Pages |
Abstract
It is generally recognized that thyroid hormone modulates osteoblast cell function. We have previously shown that triiodothyronine (T3) activates p38 mitogen-activated protein (MAP) kinase, resulting in the synthesis of osteocalcin in osteoblast-like MC3T3-E1 cells. In the present study, we investigated the effect of the adenylyl cyclase-cAMP system on thyroid hormone-stimulated osteocalcin synthesis in these cells. Dibutyryl-cAMP (DBcAMP) reduced the osteocalcin synthesis stimulated by T3. Forskolin and cholera toxin suppressed the osteocalcin synthesis while dideoxyforskolin, a forskolin derivative that does not activate adenylyl cyclase, had little effect on the synthesis. KT5720, a selective inhibitor of protein kinase A, reversed the inhibitory effect of forskolin or DBcAMP. DBcAMP and forskolin markedly reduced the phosphorylation of p38 MAP stimulated by T3. Pituitary adenylate cyclase-activating polypeptide (PACAP) significantly inhibited the T3-stimulated osteocalcin synthesis. These results strongly suggest that the adenylyl cyclase-cAMP system has an inhibitory role in thyroid hormone-stimulated osteocalcin synthesis via suppression of p38 MAP kinase activation in osteoblasts.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Yosuke Kanno, Akira Ishisaki, Minoru Yoshida, Keiichi Nakajima, Haruhiko Tokuda, Osamu Numata, Osamu Kozawa,